Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Cooper Hospital University Medical Center
2376
mi
from 98109
Camden, NJ
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Cooper Hospital University Medical Center
2376
mi
from 98109
Camden, NJ
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Margaret R Pardee Memorial Hospital
2203
mi
from 98109
Hendersonville, NC
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Margaret R Pardee Memorial Hospital
2203
mi
from 98109
Hendersonville, NC
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Summa Akron City Hospital/Cooper Cancer Center
2042
mi
from 98109
Akron, OH
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Summa Akron City Hospital/Cooper Cancer Center
2042
mi
from 98109
Akron, OH
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
2007
mi
from 98109
Columbus, OH
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
2007
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Providence Saint Vincent Medical Center
148
mi
from 98109
Portland, OR
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Providence Saint Vincent Medical Center
148
mi
from 98109
Portland, OR
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Fox Chase Cancer Center
2373
mi
from 98109
Philadelphia, PA
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Fox Chase Cancer Center
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Marshfield Clinic
1542
mi
from 98109
Marshfield, WI
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Marshfield Clinic
1542
mi
from 98109
Marshfield, WI
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Saint Nicholas Hospital
1676
mi
from 98109
Sheboygan, WI
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Nicholas Hospital
1676
mi
from 98109
Sheboygan, WI
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Oncare Hawaii Inc-Pali Momi
2678
mi
from 98109
'Aiea, HI
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Oncare Hawaii Inc-Pali Momi
2678
mi
from 98109
'Aiea, HI
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Pali Momi Medical Center
2678
mi
from 98109
'Aiea, HI
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Pali Momi Medical Center
2678
mi
from 98109
'Aiea, HI
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Union Hospital of Cecil County
2353
mi
from 98109
Elkton, MD
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Union Hospital of Cecil County
2353
mi
from 98109
Elkton, MD
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Lakeland Hospital
1780
mi
from 98109
Saint Joseph, MI
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Lakeland Hospital
1780
mi
from 98109
Saint Joseph, MI
Click here to add this to my saved trials
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated:  12/31/1969
Wright-Patterson Medical Center
1965
mi
from 98109
Wright-Patterson Air Force Base, OH
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Status: Enrolling
Updated: 12/31/1969
Wright-Patterson Medical Center
1965
mi
from 98109
Wright-Patterson Air Force Base, OH
Click here to add this to my saved trials
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Georgia
2178
mi
from 98109
Atlanta, GA
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Georgia
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated:  12/31/1969
University of Iowa
1556
mi
from 98109
Iowa City, IA
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated: 12/31/1969
University of Iowa
1556
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated:  12/31/1969
University of Toronto
2065
mi
from 98109
Toronto,
Patient Activation After DXA Result Notification
Patient Activation After DXA Result Notification
Status: Enrolling
Updated: 12/31/1969
University of Toronto
2065
mi
from 98109
Toronto,
Click here to add this to my saved trials
Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial
Phase IIB Randomized Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial
Phase IIB Randomized Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
HIV Accelerated Liver Disease in Uganda
HIV-Accelerated Liver Disease in Uganda
Status: Enrolling
Updated:  12/31/1969
National Institute of Allergy and Infectious Diseases (NIAID), 9000 Rockville Pi
2315
mi
from 98109
Bethesda, MD
HIV Accelerated Liver Disease in Uganda
HIV-Accelerated Liver Disease in Uganda
Status: Enrolling
Updated: 12/31/1969
National Institute of Allergy and Infectious Diseases (NIAID), 9000 Rockville Pi
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
2009
mi
from 98109
Columbus, OH
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
2009
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
959
mi
from 98109
Los Angeles, CA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
959
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Medical Center
2429
mi
from 98109
Hartford, CT
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Medical Center
2429
mi
from 98109
Hartford, CT
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Emory Children's Center
2180
mi
from 98109
Atlanta, GA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Emory Children's Center
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
1733
mi
from 98109
Chicago, IL
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Riley Children's Hospital
1867
mi
from 98109
Indianapolis, IN
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Riley Children's Hospital
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
John Hopkins Children's Hospital
2328
mi
from 98109
Baltimore, MD
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
John Hopkins Children's Hospital
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Goryeb Children's Hospital / Atlantic Health
2377
mi
from 98109
Morristown, NJ
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Goryeb Children's Hospital / Atlantic Health
2377
mi
from 98109
Morristown, NJ
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Women and Children's Hospital of Buffalo
2109
mi
from 98109
Buffalo, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Women and Children's Hospital of Buffalo
2109
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Cohen Children's Medical Center
2416
mi
from 98109
New Hyde Park, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Cohen Children's Medical Center
2416
mi
from 98109
New Hyde Park, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Morgan Stanley Children's Hospital
2400
mi
from 98109
New York, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Morgan Stanley Children's Hospital
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Mt Sinai Hospital
2402
mi
from 98109
New York, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Mt Sinai Hospital
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Golisano Children's Hospital SUNY Upstate Medical University
2232
mi
from 98109
Syracuse, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Golisano Children's Hospital SUNY Upstate Medical University
2232
mi
from 98109
Syracuse, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
2009
mi
from 98109
Columbus, OH
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
2009
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
2373
mi
from 98109
Philadelphia, PA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
2134
mi
from 98109
Pittsburgh, PA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Hasbro Children's Hospital
2486
mi
from 98109
Providence, RI
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Hasbro Children's Hospital
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Monroe Carell Jr. Children's Hospital at Vanderbilt
1970
mi
from 98109
Nashville, TN
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Monroe Carell Jr. Children's Hospital at Vanderbilt
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
UT Southwestern
1682
mi
from 98109
Dallas, TX
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
UT Southwestern
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Primary Children's Medical Center - University of Utah
703
mi
from 98109
Salt Lake City, UT
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Primary Children's Medical Center - University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Boston
2484
mi
from 98109
Boston, MA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Boston
2484
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center
1393
mi
from 98109
Minneapolis, MN
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
IWK Health Centre
2752
mi
from 98109
Halifax,
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
IWK Health Centre
2752
mi
from 98109
Halifax,
Click here to add this to my saved trials
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: Enrolling
Updated:  12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: Enrolling
Updated: 12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials